tiprankstipranks
PTC Therapeutics (PTCT)
NASDAQ:PTCT
US Market
PTCT
PTC Therapeutics
RESEARCH TOOLSreports
Want to see PTCT full AI Analyst Report?

PTC Therapeutics (PTCT) Income Statement

407 Followers

PTC Therapeutics Income Statement

Last quarter (Q1 2026), PTC Therapeutics's total revenue was $272.55M, a decrease of -76.83% from the same quarter last year. In Q1, PTC Therapeutics's net income was $-2.81M. See PTC Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 1.73B$ 806.78M$ 937.82M$ 698.80M$ 538.59M
Gross Profit
$ 1.66B$ 749.38M$ 872.34M$ 654.12M$ 506.26M
Operating Expenses
$ 802.39M$ 1.05B$ 1.31B$ 1.10B$ 880.71M
Depreciation and Amortization
$ 38.81M$ 75.66M$ 236.59M$ 128.84M$ 64.13M
EBITDA
$ 887.66M$ -120.46M$ -330.34M$ -367.78M$ -368.18M
Operating Income
$ 856.51M$ -302.57M$ -439.50M$ -447.41M$ -374.44M
Other Income/Expenses
$ -159.89M$ -60.55M$ -256.61M$ -140.08M$ -143.90M
Pretax Income
$ 696.62M$ -363.12M$ -696.11M$ -587.49M$ -518.34M
Net Income
$ 682.64M$ -363.30M$ -626.60M$ -559.02M$ -523.90M
Per Share Metrics
Basic EPS
$ 8.58$ -4.73$ -8.37$ -7.79$ -7.43
Diluted EPS
$ 7.78$ -4.73$ -8.37$ -7.79$ -7.43
Weighted Average Shares Outstanding
 79.53M 76.85M 74.84M 71.73M 70.47M
Weighted Average Shares Outstanding (Diluted)
 88.31M 76.85M 74.84M 71.73M 70.47M
Currency in USD

PTC Therapeutics Earnings and Revenue History